Literature DB >> 21818761

A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects.

Haseeb Ahmad Khan1, Abdullah Saleh Alhomida.   

Abstract

Radiation therapy is a key modality in the treatment of different cancer types. Fatigue is the most common side effect of radiotherapy, while others include nausea, hair loss, skin irritation, anemia, infertility, cardiovascular disease, cognitive impairment and even the development of second cancers. Studies in experimental animals have shown protective effects of carnitine against exposure of various organs to ionizing radiation, whereas carnitine deficiency is known to enhance radiation-induced toxicity. This report summarizes the recent literature on the adverse effects of radiotherapy and the impact of radiation on carnitine homeostasis. Although some studies have demonstrated the prophylactic benefits of carnitine against the toxic effects of chemotherapy, the role of carnitine in the prognosis and management of cancer patients receiving radiotherapy is not clear and needs to be explored. 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818761     DOI: 10.1002/jat.1716

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  8 in total

1.  The Etiology and management of radiotherapy-induced fatigue.

Authors:  Chao-Pin Hsiao; Barbara Daly; Leorey N Saligan
Journal:  Expert Rev Qual Life Cancer Care       Date:  2016-06-07

2.  Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.

Authors:  Evagelia C Laiakis; Tytus D Mak; Sebastien Anizan; Sally A Amundson; Christopher A Barker; Suzanne L Wolden; David J Brenner; Albert J Fornace
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

3.  Photochemotherapeutic Properties of a Linear Tetrapyrrole Palladium(II) Complex displaying an Exceptionally High Phototoxicity Index.

Authors:  Andrea M Potocny; Rachel S Riley; Rachel K O'Sullivan; Emily S Day; Joel Rosenthal
Journal:  Inorg Chem       Date:  2018-08-22       Impact factor: 5.165

4.  Lower carnitine plasma values from malnutrition cancer patients.

Authors:  Estela Iraci Rabito; Izabel Arruda Leme; Rafael Demenice; Guilherme Vannucchi Portari; Alceu Afonso Jordão; José Sebastião dos Santos; Júlio Sérgio Marchini
Journal:  J Gastrointest Cancer       Date:  2013-09

5.  Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway.

Authors:  Wenwen Xu; Jim Jun-hui Huang; Peter Chi Keung Cheung
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.

Authors:  Hironao Okubo; Hitoshi Ando; Kei Ishizuka; Ryuta Kitagawa; Shoki Okubo; Hiroaki Saito; Shigehiro Kokubu; Akihisa Miyazaki; Kenichi Ikejima; Shuichiro Shiina; Akihito Nagahara
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

Review 7.  Scribbling the Cat: A Case of the "Miracle" Plant, Moringa oleifera.

Authors:  Thulani Tshabalala; Bhekumthetho Ncube; Ntakadzeni Edwin Madala; Trevor Tapiwa Nyakudya; Hloniphani Peter Moyo; Mbulisi Sibanda; Ashwell Rungano Ndhlala
Journal:  Plants (Basel)       Date:  2019-11-15

8.  Soluble extract from Moringa oleifera leaves with a new anticancer activity.

Authors:  Il Lae Jung
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.